NCT06991374

Brief Summary

In this study, we compared two types of phacoemulsification commonly used in cataract surgery to evaluate their effect on the prognosis of patients with hard nuclei. This will provide a theoretical basis for selecting a more appropriate cataract surgery modality in practice in hard-nucleus patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
207

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 10, 2022

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 25, 2024

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 20, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 28, 2025

Completed
Last Updated

May 28, 2025

Status Verified

May 1, 2025

Enrollment Period

2.4 years

First QC Date

May 20, 2025

Last Update Submit

May 20, 2025

Conditions

Keywords

Hard nuclear cataractphacoemulisification modeultrasound timecumulative dissipated energy

Outcome Measures

Primary Outcomes (4)

  • Endothelial cell density

    Endothelial cell density after cataract surgery.

    At 1day, 1week, 1month, 3months postoperatively.

  • central cornea thickness

    central cornea thickness after cataract surgery.

    At 1day, 1week, 1month, 3months postoperatively.

  • ultrasound time

    ultrasound time during phacoemulsification.

    During cataract surgery

  • cumulative dissipated energy

    cumulative dissipated energy during phacoemulsification.

    During cataract surgery

Secondary Outcomes (3)

  • best-corrected distance visual acuity

    At 1day, 1week, 1month, 3months postoperatively.

  • cornea edema

    At 1day, 1week, 1month, 3months postoperatively.

  • occlusion

    during surgery

Study Arms (2)

Combined burst mode

EXPERIMENTAL

combining the torsional and vertical ultrasound under burst mode(Burst Tor+ Burst US) Phacoemulsification mode Brust mode Torsional amplitude 0-90% Longitudinal power 40% Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration 70 ms Off time 50 ms

Procedure: combined burst mode

torsional mode

ACTIVE COMPARATOR

torsional mode under continues mode (Linear Tor) Phacoemulsification mode Continuous mode Torsional amplitude 0-90% Longitudinal power 0 Infusion system Gravity fed Bottle height 50-80 cm Vacuum 360 mmHg Aspiration flow rate 30 cm3/min Burst duration - Off time -

Procedure: torsional mode

Interventions

the combined burst mode is commonly used in cataract phacoemulsification. This study compares whether the two modes have different outcomes in hard nuclear cataract surgery.

Combined burst mode

the toesional mode is commonly used in cataract phacoemulsification. This study compares whether the two modes have different outcomes in hard nuclear cataract surgery.

torsional mode

Eligibility Criteria

Age50 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with age-related cataracts that were only classified by Emery-Little as nuclear hardness grade III-V.
  • encompassed a minimum dilated pupil diameter of 7 mm or above, as well as a corneal endothelial cell count exceeding 1200/mm\^2.
  • Corneal morphology is normal and clear
  • Informed consent is required prior to enrollment

You may not qualify if:

  • Those with white cataracts, histories of eye surgery, and eye diseases such as corneal pathology, uveitis, Fuchs\' dystrophy, and glaucoma were excluded.
  • Exclude those with comorbid ocular and systemic diseases that affect corneal endothelial cell function
  • Exclude those with previous intraocular surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eye and ENT Hospital, Fudan University

Shanghai, Shanghai Municipality, 200031, China

Location

Related Publications (1)

  • Liu Y, Zeng M, Liu X, Luo L, Yuan Z, Xia Y, Zeng Y. Torsional mode versus conventional ultrasound mode phacoemulsification: randomized comparative clinical study. J Cataract Refract Surg. 2007 Feb;33(2):287-92. doi: 10.1016/j.jcrs.2006.10.044.

    PMID: 17276271BACKGROUND

Study Officials

  • Yinghong Ji, Phd

    Eye & ENT Hospital, Fudan University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: all individuals scheduled for cataract surgery were randomly allocated to either the combined mode group (Burst Tor+ Burst US, Group A) or the torsional mode group (Linear Tor, Group B), utilizing an online random number generator.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 20, 2025

First Posted

May 28, 2025

Study Start

August 10, 2022

Primary Completion

December 25, 2024

Study Completion

March 1, 2025

Last Updated

May 28, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Study Protocol, Statistical Analysis Plan, and Informed Consent Form will be shared.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
2024.1.26, for 1month
Access Criteria
researchers and public

Locations